Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Brian P. McDonough, MD, FAAFP
Richard Kim, MD
The Epigenetics of Lung Cancer Dormancy and Relapse
How Delayed Colorectal Cancer Screening Impacts Quality of Life
Christopher Cann, MD
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD
Tsewang Tashi, MD
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Improving CRC Screening Uptake: An Integrated Approach
Mallik Greene, PhD
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Marwan G. Fakih, MD
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Ryan Quigley
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP
Komal Jhaveri, MD, FACP
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
All Sides of the Joint: Integrated TGCT Care Across Specialties
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
The Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Protecting Heart Health in Metastatic Breast Cancer
Gregory Vidal, MD, PhD
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Evolving Approaches to Early-Onset CRC Detection
Personalized Risk Communication and Its Effect on CRC Screening Choice
Advancing Care for Men with Breast Cancer
Jose Pablo Leone, MD
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.